Trial Profile
Long-term effectiveness and safety of natalizumab in a Portuguese cohort
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Feb 2016 New trial record